Immunovant
Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases.

Year Established: 2018
Stock Ticker: IMVT
Exchange: NASDAQ
Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases.


Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases.

Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases.